Genetically elevated LDL‐cholesterol concentration based on variants in the HMGCR region is known to be associated with increased risk of CHD (Cholesterol Treatment Trialists, 2010; Ference et al., 2019). The gene discussed is HMGCR; the disease is coronary artery disorder.